Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
EditorialCovid-19 Commentaries
Open Access

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences

Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein and Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: https://doi.org/10.2967/jnumed.120.245738
Johannes Czernin
1Ahmanson Translation Imaging Division, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Fanti
2Department of Oncology, Division of Nuclear Medicine, University of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp T. Meyer
3Department of Nuclear Medicine, Medical Centre – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Allen-Auerbach
1Ahmanson Translation Imaging Division, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
4Department of Nuclear Medicine; Medical University of Vienna, Vienna General Hospital, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Sathekge
5Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney Hicks
6Molecular Imaging and Therapeutic Nuclear Medicine, the Peter MacCallum Cancer Centre, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew M. Scott
7Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
8Department of Quantum Cancer Therapy, Research Centre for Nuclear Physics, Osaka University, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mijin Yun
9Department of Nuclear Medicine; Yonsei University Hospital System, Seoul, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heiko Schöder
10Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
11Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
12Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    18F-FDG PET/CT in a 53-y-old patient with NET of the pancreas (G3 tumor) referred for restaging. At the time of the PET scan, the patient was completely asymptomatic. The current 18F-FDG PET/CT displays a new hypermetabolic area in the right upper and lower lobe (SUVmax 5.5), in topographic correlation to predominantly in the periphery/subpleurally located ground glass opacities with beginning, partly round shaped consolidations consistent with atypical inflammation. Later COVID-19 infection was confirmed.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (5)
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein, Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: 10.2967/jnumed.120.245738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein, Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: 10.2967/jnumed.120.245738
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • STEFANO FANTI, MD: DEPARTMENT OF ONCOLOGY, DIVISION OF NUCLEAR MEDICINE, UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY
    • KEN HERRMANN, MD, MBA: CHAIR, DEPARTMENT OF NUCLEAR MEDICINE, UNIVERSITÄTSKLINIKUM ESSEN, ESSEN, GERMANY
    • PHILIPP T. MEYER, MD, PHD: CHAIR, DEPARTMENT OF NUCLEAR MEDICINE, MEDICAL CENTRE – UNIVERSITY OF FREIBURG, FREIBURG, GERMANY
    • MARTIN ALLEN-AUERBACH, MD: DIRECTOR OF NUCLEAR MEDICINE, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA, LOS ANGELES, CALIFORNIA
    • MARCUS HACKER, MD: DIRECTOR OF NUCLEAR MEDICINE, MEDICAL UNIVERSITY OF VIENNA, VIENNA GENERAL HOSPITAL, VIENNA, AUSTRIA
    • MIKE SATHEKGE, MD, PHD: HEAD OF NUCLEAR MEDICINE DEPARTMENT, UNIVERSITY OF PRETORIA AND STEVE BIKO ACADEMIC HOSPITAL, PRETORIA, SOUTH AFRICA
    • RODNEY HICKS, MD: DIRECTOR, MOLECULAR IMAGING AND THERAPEUTIC NUCLEAR MEDICINE, THE PETER MACCALLUM CANCER CENTRE, MELBOURNE, AUSTRALIA
    • ANDREW SCOTT, MD: DIRECTOR, DEPARTMENT OF MOLECULAR IMAGING AND THERAPY, AUSTIN HEALTH, MELBOURNE, AUSTRALIA
    • JUN HATAZAWA, MD, PHD: DEPARTMENT OF QUANTUM CANCER THERAPY, RESEARCH CENTRE FOR NUCLEAR PHYSICS, OSAKA UNIVERSITY, OSAKA, JAPAN
    • MIJIN YUN, MD: DEPARTMENT OF NUCLEAR MEDICINE, YONSEI UNIVERSITY HOSPITAL SYSTEM, SEOUL, SOUTH KOREA
    • HEIKO SCHÖDER, MD, MBA: CHIEF, MOLECULAR IMAGING AND THERAPY SERVICE, DEPARTMENT OF RADIOLOGY, MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC), NEW YORK, NEW YORK
    • SUMMARY
    • TAKE HOME MESSAGES
    • DISCLOSURE
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
  • Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020
  • Post-COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective
  • The Impact of COVID-19 on the Health-Care Workforce: from Heroes to Zeroes?
  • Two Leaders
  • Dr. Li Wenliang and the Time of COVID-19
  • Google Scholar

More in this TOC Section

  • Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
  • Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Show more Covid-19 Commentaries

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire